Patent | Date |
---|
Benzimidazole Derivatives As Dual Histamine H1 And Histamine H4 Receptor Ligands App 20220281839 - BERREBI-BERTRAND; Isabelle ;   et al. | 2022-09-08 |
Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands Grant 11,306,069 - Berrebi-Bertrand , et al. April 19, 2 | 2022-04-19 |
Novel Combinations Of A H3 Antagonist And A Noradrenaline Reuptake Inhibitor, And The Therapeutical Uses Thereof App 20220079932 - LIGNEAU; Xavier ;   et al. | 2022-03-17 |
Combinations of a H3 antagonist and a noradrenaline reuptake inhibitor, and the therapeutical uses thereof Grant 11,229,632 - Ligneau , et al. January 25, 2 | 2022-01-25 |
Tetrahydrate of H3 ligand, its process of preparation and pharmaceutical compositions comprising the same Grant 11,078,183 - Capet , et al. August 3, 2 | 2021-08-03 |
Combination of adrenalin with an antidepressant for use in the treatment of shocks Grant 10,952,987 - Schwartz , et al. March 23, 2 | 2021-03-23 |
Novel Combinations Of A H3 Antagonist And A Noradrenaline Reuptake Inhibitor, And The Therapeutical Uses Thereof App 20200030310 - LIGNEAU; Xavier ;   et al. | 2020-01-30 |
Benzimidazole Derivatives As Dual Histamine H1 And Histamine H4 Receptor Ligands App 20190144421 - BERREBI-BERTRAND; Isabelle ;   et al. | 2019-05-16 |
Combination Of Adrenalin With An Antidepressant For Use In The Treatment Of Shocks App 20190117614 - SCHWARTZ; Jean-Charles ;   et al. | 2019-04-25 |
Form of administration of enkephalinase inhibitor Grant 9,439,853 - Julien , et al. September 13, 2 | 2016-09-13 |
Piperidinyl monocarboxylic acids as S1P1 receptor agonists Grant 9,266,867 - Capet , et al. February 23, 2 | 2016-02-23 |
6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepines derivatives as histamine H4 receptor ligands Grant 9,255,101 - Berrebi-Bertrand , et al. February 9, 2 | 2016-02-09 |
A Combination of Adrenaline with an Antidepressant for Use in the Treatment of Shocks App 20150306065 - SCHWARTZ; Jean-Charles ;   et al. | 2015-10-29 |
Benzazole derivatives as histamine H4 receptor ligands Grant 9,029,357 - Berrebi-Bertrand , et al. May 12, 2 | 2015-05-12 |
Benzazole Derivatives as Histamine H4 Receptor Ligands App 20150004181 - BERREBI-BERTRAND; Isabelle ;   et al. | 2015-01-01 |
Dicarboxylic acid derivatives as S1P1 receptor agonists Grant 8,809,539 - Capet , et al. August 19, 2 | 2014-08-19 |
Carbonylated (aza) cyclohexanes as dopamine D.sub.3 receptor ligands Grant 8,802,678 - Capet , et al. August 12, 2 | 2014-08-12 |
Form of Administration of Enkephalinase Inhibitor App 20130331423 - Julien; Jean-Stephane ;   et al. | 2013-12-12 |
Novel (aza)Benzhydryl Ether Derivatives, Their Process of Preparation and Their Use as H4-Receptor Ligands for Therapeutical Applications App 20130324507 - BERREBI-BERTRAND; Isabelle ;   et al. | 2013-12-05 |
New 6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepines derivatives as histamine H4 receptor ligands App 20130324506 - BERREBI-BERTRAND; Isabelle ;   et al. | 2013-12-05 |
Benzazole Derivatives as Histamine H4 Receptor Ligands App 20130231329 - Berrebi-Bertrand; Isabelle ;   et al. | 2013-09-05 |
Treatment of Parkinson's disease, obstructive sleep apnea, dementia with Lewy bodies, vascular dementia with non-imidazole alkylamines histamine H.sub.3-receptor ligands Grant 8,486,947 - Schwartz , et al. July 16, 2 | 2013-07-16 |
Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy]propyl]-piperidine Grant 8,354,430 - Raga , et al. January 15, 2 | 2013-01-15 |
Form of administration of racecadotril Grant 8,318,203 - Schwartz , et al. November 27, 2 | 2012-11-27 |
Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy] propyl] -piperidine Grant 8,207,197 - Raga , et al. June 26, 2 | 2012-06-26 |
Novel Pharmaceutically Acceptable Salts Of 4-(1h-imidazol-4-ylmethyl)pyridine And Their Therapeutical Uses App 20120129892 - Capet; Marc ;   et al. | 2012-05-24 |
Combination product comprising an antagonist or inverse agonist of histamine receptor H.sub.3 and an antipsychotic and antidepressant agent, and use thereof for the preparation of a medicament that prevents the adverse effects of psychotropic drugs Grant 8,106,041 - Schwartz , et al. January 31, 2 | 2012-01-31 |
Histamine H3-receptor ligands and their therapeutic applications Grant 8,076,329 - Bertrand , et al. December 13, 2 | 2011-12-13 |
Histamine H.sub.3-receptor ligands and their therapeutic application Grant 8,017,646 - Bertrand , et al. September 13, 2 | 2011-09-13 |
Combination Of Modafinil And An Antagonist Or Inverse Agonist Of The H3 Receptor App 20090312367 - Schwartz; Jean-Charles ;   et al. | 2009-12-17 |
Arylpiperaszine derivatives, to the process for the production thereof and to the use thereof as therapeutic agents Grant 7,432,269 - Capet , et al. October 7, 2 | 2008-10-07 |
Arylpiperazine Derivatives and their Use as Selective Dopamine D3 Receptor Ligands App 20080214542 - Capet; Marc ;   et al. | 2008-09-04 |
Formulation Grant 6,919,093 - Lecomte , et al. July 19, 2 | 2005-07-19 |
LTA4 hydrolase inhibitors Grant 6,878,723 - Danvy , et al. April 12, 2 | 2005-04-12 |
Process for synthesizing N-(mercaptoacyl) amino acid derivatives from alpha-substituted acrylic acids Grant 6,835,851 - Monteil , et al. December 28, 2 | 2004-12-28 |